These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 24804978)

  • 1. Molecular and clinical characterization of glucokinase maturity-onset diabetes of the young (GCK-MODY) in Japanese patients.
    Kawakita R; Hosokawa Y; Fujimaru R; Tamagawa N; Urakami T; Takasawa K; Moriya K; Mizuno H; Maruo Y; Takuwa M; Nagasaka H; Nishi Y; Yamamoto Y; Aizu K; Yorifuji T
    Diabet Med; 2014 Nov; 31(11):1357-62. PubMed ID: 24804978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GCK gene mutations are a common cause of childhood-onset MODY (maturity-onset diabetes of the young) in Turkey.
    Haliloglu B; Hysenaj G; Atay Z; Guran T; Abalı S; Turan S; Bereket A; Ellard S
    Clin Endocrinol (Oxf); 2016 Sep; 85(3):393-9. PubMed ID: 27256595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic and clinical characteristics of Chinese children with Glucokinase-maturity-onset diabetes of the young (GCK-MODY).
    Li X; Ting TH; Sheng H; Liang CL; Shao Y; Jiang M; Xu A; Lin Y; Liu L
    BMC Pediatr; 2018 Mar; 18(1):101. PubMed ID: 29510678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insights into pathogenesis of five novel GCK mutations identified in Chinese MODY patients.
    Liu L; Liu Y; Ge X; Liu X; Chen C; Wang Y; Li M; Yin J; Zhang J; Chen Y; Zhang R; Jiang Y; Zhao W; Yang D; Zheng T; Lu M; Zhuang L; Jiang M
    Metabolism; 2018 Dec; 89():8-17. PubMed ID: 30257192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atypical phenotype associated with reported GCK exon 10 deletions: Clinical judgement is needed alongside appropriate genetic investigations.
    Thanabalasingham G; Kaur K; Talbot F; Colclough K; Mathews A; Taylor J; Ellard S; Owen KR
    Diabet Med; 2013 Aug; 30(8):e233-8. PubMed ID: 23586928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. "Pesto" Mutation: Phenotypic and Genotypic Characteristics of Eight GCK/MODY Ligurian Patients.
    Salina A; Bassi M; Aloi C; Strati MF; Bocciardi R; d'Annunzio G; Maghnie M; Minuto N
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insights from basic adjunctive examinations of GCK-MODY, HNF1A-MODY, and type 2 diabetes: A systemic review and meta-analysis.
    Liu J; Xiao X; Zhang Q; Yu M
    J Diabetes; 2023 Jun; 15(6):519-531. PubMed ID: 37226652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Caudal regression syndrome in a fetus of a glucokinase-maturity-onset diabetes of the young pregnancy.
    Taylor RAM; Mackie A; Mogra R; Pinner J; Rajendran S; Ross GP
    Diabet Med; 2019 Feb; 36(2):252-255. PubMed ID: 30362177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A three-year follow-up observation of a pedigree of maturity onset diabetes of the young caused by a novel mutation of glucokinase and literature review].
    Ma ML; Ping F; Chang YS; Li YX
    Zhonghua Nei Ke Za Zhi; 2020 May; 59(5):366-371. PubMed ID: 32370465
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical profiling and screening for HNF4α and GCK gene mutations in Kashmiri patients with maturity-onset diabetes of the young (MODY).
    Firdous P; Hassan T; Nissar K; Masoodi SR; Ganai BA
    Prim Care Diabetes; 2022 Apr; 16(2):325-332. PubMed ID: 35131168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recognition and Management of Individuals With Hyperglycemia Because of a Heterozygous Glucokinase Mutation.
    Chakera AJ; Steele AM; Gloyn AL; Shepherd MH; Shields B; Ellard S; Hattersley AT
    Diabetes Care; 2015 Jul; 38(7):1383-92. PubMed ID: 26106223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pregnancy in Women With Monogenic Diabetes due to Pathogenic Variants of the Glucokinase Gene: Lessons and Challenges.
    Timsit J; Ciangura C; Dubois-Laforgue D; Saint-Martin C; Bellanne-Chantelot C
    Front Endocrinol (Lausanne); 2021; 12():802423. PubMed ID: 35069449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical screening for GCK-MODY in 2,989 patients from the Brazilian Monogenic Diabetes Study Group (BRASMOD) and the Brazilian Type 1 Diabetes Study Group (BrazDiab1SG).
    Peixoto-Barbosa R; Calliari LE; Crispim F; Moisés RS; Dib SA; Reis AF; Giuffrida FMA
    Arch Endocrinol Metab; 2024; 68():e230314. PubMed ID: 39420902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucokinase mutations in pediatric patients with impaired fasting glucose.
    Aloi C; Salina A; Minuto N; Tallone R; Lugani F; Mascagni A; Mazza O; Cassanello M; Maghnie M; d'Annunzio G
    Acta Diabetol; 2017 Oct; 54(10):913-923. PubMed ID: 28726111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of HbA1c in the identification of patients with hyperglycaemia caused by a glucokinase mutation: observational case control studies.
    Steele AM; Wensley KJ; Ellard S; Murphy R; Shepherd M; Colclough K; Hattersley AT; Shields BM
    PLoS One; 2013; 8(6):e65326. PubMed ID: 23799006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenotype Heterogeneity in Glucokinase-Maturity-Onset Diabetes of the Young (GCK-MODY) Patients.
    Wędrychowicz A; Tobór E; Wilk M; Ziółkowska-Ledwith E; Rams A; Wzorek K; Sabal B; Stelmach M; Starzyk JB
    J Clin Res Pediatr Endocrinol; 2017 Sep; 9(3):246-252. PubMed ID: 28663157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. beta-cell genes and diabetes: quantitative and qualitative differences in the pathophysiology of hepatic nuclear factor-1alpha and glucokinase mutations.
    Pearson ER; Velho G; Clark P; Stride A; Shepherd M; Frayling TM; Bulman MP; Ellard S; Froguel P; Hattersley AT
    Diabetes; 2001 Feb; 50 Suppl 1():S101-7. PubMed ID: 11272165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The glucokinase mutation p.T206P is common among MODY patients of Jewish Ashkenazi descent.
    Gozlan Y; Tenenbaum A; Shalitin S; Lebenthal Y; Oron T; Cohen O; Phillip M; Gat-Yablonski G
    Pediatr Diabetes; 2012 Sep; 13(6):e14-21. PubMed ID: 21978167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A single dose of dapagliflozin, an SGLT-2 inhibitor, induces higher glycosuria in GCK- and HNF1A-MODY than in type 2 diabetes mellitus.
    Hohendorff J; Szopa M; Skupien J; Kapusta M; Zapala B; Platek T; Mrozinska S; Parpan T; Glodzik W; Ludwig-Galezowska A; Kiec-Wilk B; Klupa T; Malecki MT
    Endocrine; 2017 Aug; 57(2):272-279. PubMed ID: 28593615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A three-step programmed method for the identification of causative gene mutations of maturity onset diabetes of the young (MODY).
    Li Q; Cao X; Qiu HY; Lu J; Gao R; Liu C; Yuan MX; Yang GR; Yang JK
    Gene; 2016 Aug; 588(2):141-8. PubMed ID: 27185633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.